PlainPill

MK-677 vs Tesamorelin for weight loss

Short answer: For weight loss, more users report improvement with Tesamorelin — 95% of 82 reports, versus 53% of 55 for MK-677.

MK-677 has 0 meta-analyses and 15 randomized trials on PubMed; Tesamorelin has 3 and 21.

Based on 978 reports about MK-677 and 265 about Tesamorelin. Not medical advice.

MK-677
Substance
Tesamorelin
Peptide
Users say it helped39%helped479 reports · high confidence58%helped119 reports · high confidence
Verdict
Mixed
Mixed
ResearchBResearch: ModerateAResearch: Strong
Meta-analyses / RCTs0 / 153 / 21
Mainly used for
Appetite
% reporting improvement
66% (228)100% (3)
Sleep
% reporting improvement
79% (170)70% (20)
Weight loss
% reporting improvement
53% (55)95% (82)
Recovery
% reporting improvement
99% (106)100% (10)
Performance
% reporting improvement
90% (87)88% (25)
Common side effectswater retention, fatigue, stomach issues, hungerwater retention, allergic reaction, anaphylaxis, swelling
Typical dose reported12.5 mg / before dinnerNot listed
MK-677
What a user said
“From my own experience (also have suffered from poor sleep), i experienced a noticeable increase in sleep quality even with a low dose.”
Full MK-677 profile →
Tesamorelin
Latest review conclusion

However, limited data on long-term safety, optimal dosing strategies, and durability of treatment effects warrant caution. Future research should evaluate extended treatment duration, dose-response relationships, and patient-reported outcomes to establish comprehensive clinical utility.

J Int Assoc Provid AIDS Care, 2026 ↗
What a user said
“I also added Tesamorelin 2 months in due to the harder time sleeping on Retatrutide and wanting to accelerate the burn of my visceral fats (2mg 5x a week). Worked like magic for me.”
Full Tesamorelin profile →

Related comparisons

Percentages come from first-hand user reports and are not clinical outcomes. Talk to a doctor before starting, stopping or combining anything. How we rate